Letrazuril
来曲珠利
Report date: 2023/04/25 15:45:45
NME
Base Information
Drug NameLetrazuril
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson Innovative Medicine
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesJanssen Pharmaceuticals IncNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A